[1] Kanda Y., Kawanishi Y., Oda K., Sakata T., Mihara S.-i., Asakura K., Kanemasa T., Ninomiya M., Fujimoto M., Konoike T.,
Synthesis and Structure–Activity Relationships of Potent and Orally Active Sulfonamide ETB Selective Antagonists,
Bioorg. Med. Chem. Lett.,
9(4): 897-907 (2001).
[2] Stokes S.S., Albert R., Buurman E.T., Andrews B., Shapiro A.B., Green O.M., McKenzie A.R., Otterbein L.R.,
Inhibitors of the Acetyltransferase Domain of N-Acetylglucosamine-1-Phosphate-Uridylyltransferase /Glucosamine-1-Phosphate-Acetyltransferase (GlmU). Part 2: Optimization of Physical Properties Leading to Antibacterial Aryl Sulfonamides,
Bioorg. Med. Chem. Lett.,
22(23): 7019-7023 (2012).
[4]Camoutsis C., Geronikaki A., Ciric A., Soković M., Zoumpoulakis P., Zervou M.,
Sulfonamide-
1, 2, 4-Thiadiazole Derivatives as Antifungal and Antibacterial Agents: Synthesis, Biological Evaluation, Lipophilicity, and Conformational Studies,
Chem. Pharm. Bull.,
58(2): 160-167 (2010).
[12] Barthel H., Rösch L., Weis J.,
Fumed Silica‐Production, Properties, and Applications, in "Organosilicon Chemistry Set: From Molecules to Materials", Auner, N., Weis, J., Editors. 1996, WILEY‐VCH Verlag GmbH & Co. KGaA. p. 761-778.